Precision BioSciences (DTIL)

Precision BioSciences (DTIL) Income Statement


Precision BioSciences Income Statement

Last quarter (Q1 2024), Precision BioSciences's total revenue was $17.58M, an increase of 65.92% from the same quarter last year. In Q1, Precision BioSciences's net income was $8.59M. See Precision BioSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 59.27M$ 48.73M$ 25.10M$ 115.53M$ 24.29M$ 22.24M
Cost of Revenue
Gross Profit
$ 59.27M$ 48.73M$ 25.10M$ 115.53M--
Operating Expense
$ 112.27M$ 92.46M$ 125.46M$ -154.91M$ 134.11M$ 109.44M
Operating Income
$ -53.00M$ -43.74M$ -100.37M$ -39.38M$ -109.83M$ -87.20M
Net Non Operating Interest Income Expense
$ 5.30M$ 5.46M$ 2.36M$ 76.00K$ 822.00K$ 4.08M
Other Income Expense
$ 3.15M$ 4.25M$ 2.19M$ -8.70M-$ -9.76M
Pretax Income
$ -50.86M$ -42.53M$ -111.64M$ -30.60M$ -109.01M$ -92.88M
Tax Provision
-$ -1.77M$ -3.00M$ -567.00K--
Earnings From Equity Interest Net Of Tax
$ -2.35M$ -4.93M$ -1.58M$ 184.00K--
Net Income Common Stockholders
$ -36.44M$ -42.53M$ -111.64M$ -30.60M$ -109.01M$ -92.88M
Basic EPS
$ 1.30$ -15.96$ -1.27$ -0.52$ -2.09$ -2.21
Diluted EPS
$ 1.30$ -15.96$ -1.27$ -0.52$ -2.09$ -2.21
Basic Average Shares
$ 345.64M$ 3.84M$ 87.90M$ 58.69M$ 52.03M$ 41.99M
Diluted Average Shares
$ 345.64M$ 3.84M$ 87.90M$ 58.69M$ 52.03M$ 41.99M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 112.27M$ 92.46M$ 125.46M$ -154.91M$ 134.11M$ 109.44M
Net Income From Continuing And Discontinued Operation
$ -36.44M$ -42.53M$ -111.64M$ -30.60M$ -109.01M$ -92.88M
Normalized Income
$ -29.19M$ -60.27M$ -92.30M-$ -109.01M$ -92.88M
Interest Expense
----$ 0.00$ 182.00K
$ -48.63M$ -42.07M$ -110.53M$ -30.47M$ -109.01M$ -92.69M
$ -40.39M$ -33.96M$ -101.58M$ -20.23M$ -99.19M$ -87.38M
Currency in USD

Precision BioSciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis